A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine.

Ohmura, S; Hanai, S; Ishihara, R; Ohkubo, Y; Miyamoto, T

Ohmura, S; Hanai, S; Ishihara, R; Ohkubo, Y; Miyamoto, T.

Afiliación

Ohmura S; Department of Rheumatology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
Hanai S; Department of Dermatology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
Ishihara R; Department of Rheumatology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
Ohkubo Y; Department of Rheumatology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
Miyamoto T; Department of Rheumatology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.

J Eur Acad Dermatol Venereol ; 36(6): e427-e429, 2022 06.

Article en En | MEDLINE | ID: mdl-35176180

Asunto(s)

Artritis Psoriásica; COVID-19; Espondiloartritis; COVID-19/prevención & control; Vacunas contra la COVID-19/efectos adversos; Humanos; ARN Mensajero; Vacunas Sintéticas; Vacunas de ARNm

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Psoriásica / Espondiloartritis / COVID-19 Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google